Table 1.
Clinical characteristics of KIRC patients
| Characteristic | Low expression of ZNF268 | High expression of ZNF268 | P-value |
|---|---|---|---|
| n | 269 | 270 | |
| T stage, n (%) | < 0.001 | ||
| T1 | 115 (21.3%) | 163 (30.2%) | |
| T2 | 40 (7.4%) | 31 (5.8%) | |
| T3 | 110 (20.4%) | 69 (12.8%) | |
| T4 | 4 (0.7%) | 7 (1.3%) | |
| N stage, n (%) | 0.834 | ||
| N0 | 120 (46.7%) | 121 (47.1%) | |
| N1 | 7 (2.7%) | 9 (3.5%) | |
| M stage, n (%) | 0.080 | ||
| M0 | 203 (40.1%) | 225 (44.5%) | |
| M1 | 46 (9.1%) | 32 (6.3%) | |
| Pathologic stage, n (%) | < 0.001 | ||
| Stage I | 112 (20.9%) | 160 (29.9%) | |
| Stage II | 32 (6%) | 27 (5%) | |
| Stage III | 75 (14%) | 48 (9%) | |
| Stage IV | 48 (9%) | 34 (6.3%) | |
| Histologic grade, n (%) | < 0.001 | ||
| G1 | 4 (0.8%) | 10 (1.9%) | |
| G2 | 94 (17.7%) | 141 (26.6%) | |
| G3 | 114 (21.5%) | 93 (17.5%) | |
| G4 | 52 (9.8%) | 23 (4.3%) | |
| OS event, n (%) | < 0.001 | ||
| Alive | 163 (30.2%) | 203 (37.7%) | |
| Dead | 106 (19.7%) | 67 (12.4%) | |
| DSS event, n (%) | 0.002 | ||
| Alive | 194 (36.7%) | 226 (42.8%) | |
| Dead | 69 (13.1%) | 39 (7.4%) |